FOR THE FIRST TIME IN THE WORLD, APPROVAL HAS BEEN GRANTED FOR THE USE OF A PERSONALIZED MRNA VACCINE
Today, a unique event took place in Russian and global medicine - the National Medical Research Radiological Centre of the Minisrty of Health of the Russian Federation, together with the N.F. Gamaleya National Research Center for Epidemiology and Microbiology, received the world's first approval for the clinical use of a personalized anti-tumor mRNA vaccine — "NEOONCOVAC".Personalized mRNA...












